rs2395228

Variant names:

• chr6-32655446-A-C
• rs2395228
• XM_006715079.5:c.*772A>C

Your query was ambiguous. Multiple possible variants found:

• chr6-32655446-A-C
• chr6-32655446-A-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_Strong BA1

The XM_006715079.5(HLA-DQA1):​c.*772A>C variant causes a downstream gene change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.115 in 124,078 control chromosomes in the GnomAD database, including 846 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

• Frequency: Genomes: 𝑓 0.12 (846 hom., cov: 29)
• Consequence: HLA-DQA1 XM_006715079.5 downstream_gene
• Clinical Significance: Not reported in ClinVar
• Conservation: PhyloP100: 0.766
• Publications: 10 publications found

Genes affected

HLA-DQA1 (HGNC:4942): (major histocompatibility complex, class II, DQ alpha 1) HLA-DQA1 belongs to the HLA class II alpha chain paralogues. The class II molecule is a heterodimer consisting of an alpha (DQA) and a beta chain (DQB), both anchored in the membrane. It plays a central role in the immune system by presenting peptides derived from extracellular proteins. Class II molecules are expressed in antigen presenting cells (APC: B Lymphocytes, dendritic cells, macrophages). The alpha chain is approximately 33-35 kDa. It is encoded by 5 exons; exon 1 encodes the leader peptide, exons 2 and 3 encode the two extracellular domains, and exon 4 encodes the transmembrane domain and the cytoplasmic tail. Within the DQ molecule both the alpha chain and the beta chain contain the polymorphisms specifying the peptide binding specificities, resulting in up to four different molecules. Typing for these polymorphisms is routinely done for bone marrow transplantation. [provided by RefSeq, Jul 2008]

ACMG classification

Our verdict: Benign. The variant received -12 ACMG points.

• BP4: Computational evidence support a benign effect (BayesDel_noAF=-0.89).
• BA1: GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.146 is higher than 0.05.

Variant Effect in Transcripts

 

RefSeq Transcripts

Sel.	Gene	Transcript	Tags	HGVSc	HGVSp	Effect	Exon Rank	Protein	UniProt
There are no transcript annotations for this variant.

Ensembl Transcripts

Sel.	Gene	Transcript	Tags	HGVSc	HGVSp	Effect	Exon Rank	Protein	UniProt
There are no transcript annotations for this variant.

Frequencies

GnomAD3 genomes AF: 0.116 AC: 14320 AN: 123982 Hom.: 845 Cov.: 29

Gnomad AFR AF: 0.0834

Gnomad AMI AF: 0.0667

Gnomad AMR AF: 0.0837

Gnomad ASJ AF: 0.0762

Gnomad EAS AF: 0.0597

Gnomad SAS AF: 0.138

Gnomad FIN AF: 0.0990

Gnomad MID AF: 0.154

Gnomad NFE AF: 0.149

Gnomad OTH AF: 0.112

We have no GnomAD4 exomes data on this position. Probably position not covered by the project.

GnomAD4 genome AF: 0.115 AC: 14327 AN: 124078 Hom.: 846 Cov.: 29 AF XY: 0.113 AC XY: 6811 AN XY: 60454

African (AFR) AF: 0.0833 AC: 2857 AN: 34282

American (AMR) AF: 0.0836 AC: 957 AN: 11450

Ashkenazi Jewish (ASJ) AF: 0.0762 AC: 200 AN: 2624

East Asian (EAS) AF: 0.0597 AC: 242 AN: 4056

South Asian (SAS) AF: 0.139 AC: 565 AN: 4072

European-Finnish (FIN) AF: 0.0990 AC: 883 AN: 8922

Middle Eastern (MID) AF: 0.158 AC: 35 AN: 222

European-Non Finnish (NFE) AF: 0.149 AC: 8355 AN: 56062

Other (OTH) AF: 0.111 AC: 185 AN: 1668

Alfa AF: 0.102 Hom.: 1231

Bravo AF: 0.0916

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name	Calibrated prediction	Score	Prediction
BayesDel_noAF	Benign	-0.89
CADD	Benign	5.1
DANN	Benign	0.60
PhyloP100		0.77

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Other links and lift over

dbSNP: rs2395228; hg19: chr6-32623223;